uniQure N.V.·4

Jan 30, 9:11 PM ET

van Deventer Sander 4

4 · uniQure N.V. · Filed Jan 30, 2020

Insider Transaction Report

Form 4
Period: 2020-01-28
Transactions
  • Sale

    Ordinary Shares

    2020-01-28$62.10/sh923$57,31843,127 total
  • Sale

    Ordinary Shares

    2020-01-28$61.27/sh1,304$79,89644,050 total
Holdings
  • Ordinary Shares

    (indirect: See footnote)
    9,859
Footnotes (3)
  • [F1]As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.85 to $61.83. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Shares held by Forbion Management. The Reporting Person is a member of Forbion's investment committee, which exercises voting and investment power over such shares. None of the members of the investment committee have individual voting and investment power with respect to such shares, and the Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein. The Reporting Person is also a partner of Forbion Capital Partners, which acts as the investment advisor to the directors of ForUniQure B.V. and Forbion 1 Management B.V. (the director of ForUniQure B.V.) with respect to Ordinary Shares held by ForUniQure B.V. The Reporting Person disclaims beneficial ownership of such Ordinary Shares, except to the extent of his proportionate pecuniary interest therein.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT